Villalba Mayte, Rodríguez Rosalía, Batanero Eva
Dpto. Bioquímica y Biología Molecular I, Facultad de C. Químicas, UCM, Madrid, Spain.
Dpto. Bioquímica y Biología Molecular I, Facultad de C. Químicas, UCM, Madrid, Spain.
Methods. 2014 Mar 1;66(1):44-54. doi: 10.1016/j.ymeth.2013.07.038. Epub 2013 Aug 3.
Olive tree is one of the main allergy sources in Mediterranean countries. The identification of the allergenic repertoire from olive pollen has been essential for the development of rational strategies of standardization, diagnosis, and immunotherapy, all of them focused to increase the life quality of the patients. From its complex allergogram, twelve allergens - Ole e 1 to Ole e 12 - have been identified and characterized to date. Most of them have been cloned and produced as recombinant forms, whose availability have allowed analyzing their three-dimensional structures, mapping their T-cell and B-cell epitopes, and determining the precise allergenic profile of patients for a subsequent patient-tailored immunotherapy. Protein mutant, hypoallergenic derivatives, or recombinant fragments have been also useful experimental tools to analyze the immune recognition of allergens. To test these molecules before using them for clinic purposes, a mouse model of allergic sensitizations has been used. This model has been helpful for assaying different prophylactic approaches based on tolerance induction by intranasal administration of allergens or hypoallergens, used as free or integrated in different delivery systems, and their findings suggest a promising utilization as nasal vaccines. Exosomes - nanovesicles isolated from bronchoalveolar lavage fluid of tolerogenic mice - have shown immunomodulatory properties, being able to protect mice against sensitization to Ole e 1.
橄榄树是地中海国家主要的过敏原之一。确定橄榄花粉中的过敏原种类对于制定标准化、诊断和免疫治疗的合理策略至关重要,所有这些策略都旨在提高患者的生活质量。从其复杂的过敏原谱中,迄今为止已鉴定并表征了12种过敏原——Ole e 1至Ole e 12。其中大多数已被克隆并以重组形式产生,其可用性使得能够分析它们的三维结构、绘制它们的T细胞和B细胞表位,并确定患者的精确过敏原谱,以便随后进行个性化免疫治疗。蛋白质突变体、低过敏原衍生物或重组片段也是分析过敏原免疫识别的有用实验工具。为了在将这些分子用于临床之前对其进行测试,已经使用了过敏性致敏的小鼠模型。该模型有助于测试基于通过鼻内给予过敏原或低过敏原诱导耐受性的不同预防方法,这些过敏原或低过敏原可以以游离形式或整合在不同的递送系统中使用,并且它们的研究结果表明其作为鼻疫苗具有广阔的应用前景。外泌体——从耐受性小鼠的支气管肺泡灌洗液中分离出的纳米囊泡——已显示出免疫调节特性,能够保护小鼠免受对Ole e 1的致敏。